Binding of semaglutide to the GLP-1 receptors of the islets of Langerhans in the pancreas leads, similarly to the regulation of eating behavior by the hypothalamus, to a decrease in glucagon production and a more significant action of insulin on the body
GLP-1 and amylin-mediated reductions in food intake produce weight loss that includes both fat and lean mass, with the ratio dependent on protein intake, physical activity, and the magnitude of caloric deficit
The product's ingredients are completely devoid of negative effects and do not contain any strong bleaching chemicals
Studies have found that the majority of people who start taking GLP-1s stop taking them within a year, and after stopping, about half begin to take the drug again
It is one of the first inflammatory signals released when the immune system perceives a threat, and in psoriasis, it acts as a master switch that amplifies virtually every other inflammatory pathway involved